Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific Data

Boehringer Ingelheim Investigational Site 23, Aachen

Boehringer Ingelheim Investigational Site 10, Berlin

Boehringer Ingelheim Investigational Site 11, Berlin

Boehringer Ingelheim Investigational Site 14, Berlin

Boehringer Ingelheim Investigational Site 19, Berlin

Boehringer Ingelheim Investigational Site 26, Berlin

Boehringer Ingelheim Investigational Site 28, Berlin

Boehringer Ingelheim Investigational Site 33, Berlin

Boehringer Ingelheim Investigational Site 4, Berlin

Boehringer Ingelheim Investigational Site 5, Berlin

Boehringer Ingelheim Investigational Site 8, Berlin

Boehringer Ingelheim Investigational Site 9, Berlin

Boehringer Ingelheim Investigational Site 31, Chemnitz

Boehringer Ingelheim Investigational Site 25, Cologne

Boehringer Ingelheim Investigational Site 29, Dortmund

Boehringer Ingelheim Investigational Site 27, Düsseldorf

Boehringer Ingelheim Investigational Site 17, Frankfurt

Boehringer Ingelheim Investigational Site 1, Frankfurt

Boehringer Ingelheim Investigational Site 2, Freiburg im Breisgau

Boehringer Ingelheim Investigational Site 34, Giessen

Boehringer Ingelheim Investigational Site 22, Hamburg

Boehringer Ingelheim Investigational Site 6, Hamburg

Boehringer Ingelheim Investigational Site 12, Hanover

Boehringer Ingelheim Investigational Site 16, Hanover

Boehringer Ingelheim Investigational Site 32, Karlsruhe

Boehringer Ingelheim Investigational Site 15, Koblenz

Boehringer Ingelheim Investigational Site 21, Leipzig

Boehringer Ingelheim Investigational Site 20, München

Boehringer Ingelheim Investigational Site 24, München

Boehringer Ingelheim Investigational Site 3, München

Boehringer Ingelheim Investigational Site 7, München

Boehringer Ingelheim Investigational Site 13, Münster

Boehringer Ingelheim Investigational Site 18, Osnabrück

Boehringer Ingelheim Investigational Site 30, Stuttgart